Nilsine Partners LLC Purchases 595 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Nilsine Partners LLC boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 9.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 6,889 shares of the medical equipment provider's stock after purchasing an additional 595 shares during the quarter. Nilsine Partners LLC's holdings in Intuitive Surgical were worth $3,596,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Mirador Capital Partners LP increased its stake in Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider's stock worth $1,732,000 after purchasing an additional 50 shares in the last quarter. M.E. Allison & CO. Inc. bought a new stake in shares of Intuitive Surgical during the fourth quarter worth $449,000. Seilern Investment Management Ltd acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $82,517,000. Exome Asset Management LLC lifted its position in Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock valued at $3,649,000 after acquiring an additional 1,069 shares in the last quarter. Finally, Consolidated Planning Corp boosted its stake in Intuitive Surgical by 17.4% in the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider's stock worth $3,979,000 after purchasing an additional 1,198 shares during the period. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Trading Up 0.1 %

ISRG stock traded up $0.66 during trading hours on Tuesday, hitting $574.14. 2,331,432 shares of the stock were exchanged, compared to its average volume of 2,043,553. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The firm has a market capitalization of $204.50 billion, a P/E ratio of 92.31, a P/E/G ratio of 5.19 and a beta of 1.39. The company has a 50-day simple moving average of $548.00 and a two-hundred day simple moving average of $506.12.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the business's stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares of the company's stock, valued at $12,391,166.97. The trade was a 42.84 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Jamie Samath sold 22,903 shares of the firm's stock in a transaction on Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the transaction, the insider now directly owns 8,757 shares of the company's stock, valued at $4,597,425. The trade was a 72.34 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 46,900 shares of company stock worth $24,590,472 over the last three months. Corporate insiders own 0.90% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on ISRG. JPMorgan Chase & Co. boosted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a report on Friday. BTIG Research upped their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a research report on Tuesday, November 26th. Oppenheimer reiterated a "market perform" rating on shares of Intuitive Surgical in a report on Friday, October 18th. Citigroup raised their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research report on Friday. Finally, Truist Financial boosted their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a "buy" rating in a research report on Friday. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.